Duos Technologies Group enters its Q1 2026 earnings call on May 18 with short sellers cutting positions, call buyers dominating the options market, and the stock up 7.6% on the week — a setup that is decidedly one-directional ahead of the print.
The most striking feature of positioning right now is how aggressively short sellers have backed off. Short interest has dropped nearly 6% over the past week to 8.1% of the free float — down from above 9.5% at the end of April — as the stock rallied through the $8–9 range. That retreat comes despite a month-on-month short interest build of roughly 3.4%, suggesting bears have been adding on dips and trimming into strength. Borrow conditions give them little reason to panic: cost to borrow is running at just 0.83%, a benign level even after rising 32% over the week. Availability has also widened from near-term tights, with the lending pool about half-utilised against a 52-week peak of 82% — meaning plenty of shares remain available if new shorts want to rebuild.
Options positioning reinforces the bullish tilt. The put/call ratio has collapsed to 0.026, almost two standard deviations below its 20-day average of 0.036 and near the lowest reading of the past year. That near-absence of put buying — against a 52-week high of 0.20 — signals the options market is firmly skewed toward calls ahead of Monday's earnings release. Whether that reflects genuine optimism or simply a thin, low-liquidity options market for a small-cap name is worth noting, but the directional lean is unambiguous.
The Street sees more room to run. Ascendiant Capital's Edward Woo lifted his price target to $17 in April — nearly double the current price of $8.97 — while maintaining his Buy rating. That raise followed a string of incremental upgrades going back to 2024, though coverage appears limited to two boutique firms. Northland Capital Markets separately carries an Outperform. Both analysts have been steadily ratcheting targets higher as the company rebuilt revenue. The Q4 full-year results confirmed that trajectory: revenue jumped to $27 million for full-year 2025, up from $7.3 million a year earlier, though the company still posted a net loss of $9.8 million. Q1 2026, already reported in the corporate events feed, shows revenue of $2.7 million against $4.95 million a year ago — a sequential pullback that the May 18 call will need to address. The company's EPS surprise factor score ranks in the 99th percentile of the universe, meaning it has a strong track record of beating estimates, which provides some cushion.
The institutional register carries a few notable datapoints. Vanguard added 285,400 shares as of March 31, while Private Advisor Group added 257,000 over the same period. Morgan Stanley nearly doubled its position in Q4 2025, adding 505,000 shares. On the other side, CEO Charles Ferry reported a reduction of 261,000 shares as of April 1 — a sale worth flagging even if the timing predates the recent rally. The most recent insider trades in the dataset are over a year old, so no fresh signal is available from that source.
Earnings history shows a muted reaction pattern: the last two confirmed post-earnings moves were +1.2% and -1.5% on the day, with one five-day window extending to +7.4%. The setup going into Monday's Q1 call — shorts retreating, calls dominating, the stock at a one-month high — means the market is already pricing in optimism. The question the call needs to answer is whether the Q1 revenue dip to $2.7 million is a timing issue related to project delivery cycles or something more structural, given that the full-year 2025 growth story was the primary catalyst for the analyst upgrades.
See the live data behind this article on ORTEX.
Open DUOT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
